These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

952 related articles for article (PubMed ID: 23935011)

  • 1. Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study.
    Sarode R; Milling TJ; Refaai MA; Mangione A; Schneider A; Durn BL; Goldstein JN
    Circulation; 2013 Sep; 128(11):1234-43. PubMed ID: 23935011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial.
    Pabinger I; Brenner B; Kalina U; Knaub S; Nagy A; Ostermann H;
    J Thromb Haemost; 2008 Apr; 6(4):622-31. PubMed ID: 18208533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of thromboembolic events after protocolized warfarin reversal with 3-factor PCC and factor VIIa.
    Barton CA; Johnson NB; Case J; Warden B; Hughes D; Zimmerman J; Roberti G; McMillian WD; Schreiber M
    Am J Emerg Med; 2015 Nov; 33(11):1562-6. PubMed ID: 26143317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial.
    Goldstein JN; Refaai MA; Milling TJ; Lewis B; Goldberg-Alberts R; Hug BA; Sarode R
    Lancet; 2015 May; 385(9982):2077-87. PubMed ID: 25728933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of a Four-factor Prothrombin Complex Concentrate Versus Plasma for Vitamin K Antagonist Reversal: An Integrated Analysis of Two Phase IIIb Clinical Trials.
    Milling TJ; Refaai MA; Sarode R; Lewis B; Mangione A; Durn BL; Harman A; Lee ML; Goldstein JN
    Acad Emerg Med; 2016 Apr; 23(4):466-75. PubMed ID: 26822172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin K Antagonist Reversal for Urgent Surgery Using 4-Factor Prothrombin Complex Concentrates: A Randomized Clinical Trial.
    Sarode R; Goldstein JN; Simonian G; Hinterberger D; Matveev D; Gareis M; Milling TJ
    JAMA Netw Open; 2024 Aug; 7(8):e2424758. PubMed ID: 39088218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACP Journal Club. 4F-PCC was noninferior to plasma in patients with acute major bleeding who needed urgent VKA reversal.
    Lang E
    Ann Intern Med; 2014 Apr; 160(8):JC6. PubMed ID: 24733223
    [No Abstract]   [Full Text] [Related]  

  • 8. Emergent reversal of vitamin K antagonists: addressing all the factors.
    Martin DT; Barton CA; Dodgion C; Schreiber M
    Am J Surg; 2016 May; 211(5):919-25. PubMed ID: 27046797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four-factor prothrombin complex concentrate for urgent reversal of vitamin K antagonists in patients with major bleeding.
    Quinlan DJ; Eikelboom JW; Weitz JI
    Circulation; 2013 Sep; 128(11):1179-81. PubMed ID: 23935012
    [No Abstract]   [Full Text] [Related]  

  • 10. Fixed-Dose Four-Factor Prothrombin Complex Concentrate for Vitamin K Antagonist Reversal: Does One Dose Fit All?
    Schwebach AA; Waybright RA; Johnson TJ
    Pharmacotherapy; 2019 May; 39(5):599-608. PubMed ID: 30892733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four-factor prothrombin complex concentrate for life-threatening bleeds or emergent surgery: A retrospective evaluation.
    Sin JH; Berger K; Lesch CA
    J Crit Care; 2016 Dec; 36():166-172. PubMed ID: 27546767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An international, multicenter, prospective study of a prothrombin complex concentrate, Prothromplex Total®, in anticoagulant reversal.
    Altorjay Á; Szabó É; Boda Z; Kramer L; Ngo LY; Engl W; Firth CL; Ahlstrom ER; Gelmont DM; Pabinger I
    Thromb Res; 2015 Mar; 135(3):485-91. PubMed ID: 25613927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of a 4-factor prothrombin complex concentrate for rapid vitamin K antagonist reversal in Japanese patients presenting with major bleeding or requiring urgent surgical or invasive procedures: a prospective, open-label, single-arm phase 3b study.
    Kushimoto S; Fukuoka T; Kimura A; Toyoda K; Brainsky A; Harman A; Chung T; Yasaka M
    Int J Hematol; 2017 Dec; 106(6):777-786. PubMed ID: 28815410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suboptimal effect of a three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose.
    Holland L; Warkentin TE; Refaai M; Crowther MA; Johnston MA; Sarode R
    Transfusion; 2009 Jun; 49(6):1171-7. PubMed ID: 19210325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective Evaluation of a Fixed-Dose 4-Factor Prothrombin Complex Concentrate Protocol for Urgent Vitamin K Antagonist Reversal.
    Bitonti MT; Rumbarger RL; Absher RK; Curran LM
    J Emerg Med; 2020 Feb; 58(2):324-329. PubMed ID: 31787372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fixed Versus Variable Dosing of Prothrombin Complex Concentrate for Bleeding Complications of Vitamin K Antagonists-The PROPER3 Randomized Clinical Trial.
    Abdoellakhan RA; Khorsand N; Ter Avest E; Lameijer H; Faber LM; Ypma PF; Nieuwenhuizen L; Veeger NJGM; Meijer K
    Ann Emerg Med; 2022 Jan; 79(1):20-30. PubMed ID: 34535300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Four-factor prothrombin complex concentrate versus plasma for urgent vitamin K antagonist reversal: new evidence.
    Sarode R
    Clin Lab Med; 2014 Sep; 34(3):613-21. PubMed ID: 25168946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboembolic Events After Vitamin K Antagonist Reversal With 4-Factor Prothrombin Complex Concentrate: Exploratory Analyses of Two Randomized, Plasma-Controlled Studies.
    Milling TJ; Refaai MA; Goldstein JN; Schneider A; Omert L; Harman A; Lee ML; Sarode R
    Ann Emerg Med; 2016 Jan; 67(1):96-105.e5. PubMed ID: 26094105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased risk of volume overload with plasma compared with four-factor prothrombin complex concentrate for urgent vitamin K antagonist reversal.
    Refaai MA; Goldstein JN; Lee ML; Durn BL; Milling TJ; Sarode R
    Transfusion; 2015 Nov; 55(11):2722-9. PubMed ID: 26135740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term safety and efficacy of a pasteurized nanofiltrated prothrombin complex concentrate (Beriplex P/N): a pharmacovigilance study.
    Hanke AA; Joch C; Görlinger K
    Br J Anaesth; 2013 May; 110(5):764-72. PubMed ID: 23335567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.